Evidence for early impairment of glucagon-like peptide 1-induced insulin secretion in human type 2 (non insulin-dependent) diabetes
GLP-1 and GIP receptor activation enhances glucose-dependent insulin secretion
(2020) 34:e4459
BPC-157 is a pentadecapeptide derived from the stomach that operates via an intricate network of cytoprotection and angiogenesis mechanisms, including VEGFR2, NO-eNOS signaling, FAK-paxillin interaction and others, with its most solid data being derived from gastrointestinal, tendon, ligament, bone, and increasingly neural studies
146,147 Another critical limitation is the delay in predictive utility: the optimal scoring time point often occurs more than 48 h after symptom onset, at which time clinical signs of SAP are typically evident, potentially missing the window for effective early intervention